parecoxib has been researched along with leukotriene b4 in 1 studies
| Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (leukotriene b4) | Trials (leukotriene b4) | Recent Studies (post-2010) (leukotriene b4) |
|---|---|---|---|---|---|
| 436 | 186 | 229 | 5,886 | 232 | 717 |
| Protein | Taxonomy | parecoxib (IC50) | leukotriene b4 (IC50) |
|---|---|---|---|
| Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candelario-Jalil, E; Fiebich, BL; Koch, FW; Seidel, MF; Ulrich-Merzenich, G; Vetter, H | 1 |
1 other study(ies) available for parecoxib and leukotriene b4
| Article | Year |
|---|---|
Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells.
Topics: Aged; Cells, Cultured; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Drug Interactions; Humans; Indoles; Interleukin-1beta; Isoxazoles; Ketanserin; Leukotriene B4; Macrophages; Middle Aged; Osteoarthritis; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin Agents; Serotonin Antagonists; Synovial Membrane; Tropisetron; Tumor Necrosis Factor-alpha | 2008 |